7.2 Potassium & Chloride Homeostasis, Pseudohyperkalemia & the Chloride Shift
Key Takeaways
- Potassium (K+) is the primary intracellular cation (~150 mmol/L intracellular vs 3.5-5.0 mmol/L extracellular), maintaining an essential 30:1 concentration gradient via Na+/K+-ATPase that dictates excitable tissue resting membrane potential (Em).
- Transcellular potassium shifts occur during acid-base disturbances: acute mineral acidosis forces extracellular H+ into cells in exchange for K+ (elevating serum K+ by ~0.4-0.6 mmol/L per 0.10 pH drop), whereas alkalosis, insulin, and beta-2 agonists drive K+ into cells.
- Pre-analytical pseudohyperkalemia is extraordinarily common in clinical laboratories, triggered by in vitro hemolysis (RBC K+ is 25-30x serum), prolonged tourniquet stasis with fist pumping, delayed centrifugation, severe thrombocytosis (>500,000-1,000,000/uL), leukocytosis (>50,000/uL), and K2EDTA tube contamination.
- The Chloride Shift (Hamburger phenomenon) maintains electroneutrality during CO2 transport: in tissue capillaries, RBC carbonic anhydrase generates HCO3-, which exits into plasma via Band 3 in exchange for Cl- entering the erythrocyte; this process reverses in pulmonary capillaries.
- Quantitative sweat chloride testing via pilocarpine iontophoresis followed by coulometric titration or ISE remains the gold standard diagnostic confirmatory test for Cystic Fibrosis (CFTR mutation), with sweat chloride >= 60 mmol/L diagnostic.
Last updated: September 2026
7.2 Potassium & Chloride Homeostasis, Pseudohyperkalemia & the Chloride Shift
[!NOTE] Critical Electrophysiological Determinant: Potassium (K+) is the predominant intracellular cation, with approximately 98% of total body potassium stores sequestered inside cells and only 2% distributed within extracellular fluid (ECF). The steep 30:1 to 35:1 intracellular-to-extracellular concentration gradient (~150 mmol/L intracellular vs 3.5 to 5.0 mmol/L extracellular) is actively maintained by the basolateral Na+/K+-ATPase pump. This chemical gradient establishes the resting membrane potential (Em) of cardiac myocytes and neuromuscular tissue, making minor extracellular potassium shifts potentially life-threatening.
Potassium Physiology & Electrophysiological Mechanics
In a healthy 70-kg adult, total body potassium is approximately 3,000 to 4,000 mmol. The normal serum potassium reference range is 3.5 to 5.0 mmol/L (or mEq/L). Clinical laboratory panic values are typically defined as < 2.8 to 3.0 mmol/L and > 6.0 to 6.5 mmol/L due to immediate risks of fatal cardiac arrhythmias.
The Nernst Equation & Resting Membrane Potential
The resting membrane potential (Em) of excitable cells is governed predominantly by potassium permeability across resting inward-rectifier potassium channels, described by the Nernst equation:
Em = (RT / zF) * ln([K+]_out / [K+]_in) ≈ -61.5 mV * log10([K+]_in / [K+]_out)
At physiological concentrations (intracellular [K+] = 150 mmol/L, extracellular [K+] = 4.0 mmol/L), the calculated equilibrium potential is approximately -90 mV:
- Hyperkalemia ([K+]_ECF elevated): Decreases the concentration gradient ([K+]_in / [K+]_out), making Em less negative (depolarized), moving it closer to the threshold potential. While this initially increases membrane excitability, persistent depolarization permanently inactivates voltage-gated sodium channels, depressing cardiac conduction velocity and causing heart block, sinus arrest, or ventricular fibrillation.
- Hypokalemia ([K+]_ECF reduced): Increases the concentration gradient, making Em more negative (hyperpolarized). This widens the distance between resting potential and threshold, decreasing membrane excitability, delaying cardiac repolarization, and predisposing to re-entrant arrhythmias and prolonged QT interval.
+-----------------------------------------------------------------------------------------+
| Renal Potassium Handling & Secretion |
+-----------------------------------------------------------------------------------------+
| Segment Potassium Handling Transport Mechanism |
+-----------------------------------------------------------------------------------------+
| Proximal Tubule (PCT) 65% - 70% Reabsorbed Passive paracellular solvent drag |
| |
| Loop of Henle (TAL) 20% - 25% Reabsorbed Apical NKCC2 cotransporter; paracellular |
| |
| Distal / Collecting Variable Net Principal Cells: Aldosterone-driven |
| Duct (CCD) Secretion secretion via apical ROMK and BK channels. |
| Intercalated Cells: H+/K+-ATPase reabsorbs. |
+-----------------------------------------------------------------------------------------+
Renal Elimination of Potassium
Approximately 90% of daily dietary potassium intake (~70-100 mmol/day) is excreted by the kidneys, with the remaining 10% eliminated in feces. The proximal convoluted tubule reabsorbs 65% to 70% of filtered potassium passively via solvent drag, and the thick ascending limb reabsorbs 20% to 25% via NKCC2. Consequently, urinary potassium excretion is determined almost entirely by active potassium secretion in the cortical collecting duct (CCD):
- Principal Cells (Potassium Secretion): Aldosterone enhances basolateral Na+/K+-ATPase activity and stimulates the insertion of apical ENaC channels. Sodium reabsorption through ENaC creates a lumen-negative transepithelial potential difference that pulls potassium out of principal cells into the tubular lumen via apical ROMK (Renal Outer Medullary Potassium) and flow-dependent BK (Big Potassium / maxi-K) channels.
- Alpha-Intercalated Cells (Potassium Reabsorption): During states of severe hypokalemia or potassium depletion, apical H+/K+-ATPase antiporters actively reabsorb potassium in exchange for hydrogen ion secretion.
Transcellular Potassium Distribution & Internal Balance
Because extracellular potassium represents only 2% of total body stores, rapid buffering of potassium loads depends on transcellular shifting between the intracellular fluid (ICF) and extracellular fluid (ECF):
+-----------------------------------------------------------------------------------------+
| Mechanisms of Transcellular Potassium Shifting |
+-----------------------------------------------------------------------------------------+
| Factor Direction of Shift Underlying Biochemical Mechanism |
+-----------------------------------------------------------------------------------------+
| Acute Mineral Acidosis ECF to ICF (K+ OUT) Extracellular H+ enters cells to be buffered;|
| (Inorganic HCl, NH4Cl) K+ exits to preserve electroneutrality. |
| |
| Metabolic Alkalosis ICF to ECF (K+ IN) H+ exits cells to buffer extracellular OH-; |
| K+ moves inward, lowering serum K+. |
| |
| Insulin ECF to ICF (K+ IN) Directly stimulates Na+/K+-ATPase activity |
| in skeletal muscle and hepatocytes. |
| |
| Beta-2 Agonists ECF to ICF (K+ IN) Beta-2 receptor -> cAMP -> PKA activates |
| (Albuterol, Epinephrine) Na+/K+-ATPase pump. |
| |
| Hyperosmolality ICF to ECF (K+ OUT) Osmotic water efflux draws intracellular K+ |
| (Hyperglycemia) out of cells via solvent drag. |
| |
| Cell Lysis / Trauma ICF to ECF (K+ OUT) Mechanical or ischemic membrane disruption |
| (Rhabdomyolysis, TLS) releases rich intracellular K+ stores. |
+-----------------------------------------------------------------------------------------+
Detailed Acid-Base Interactions
- Inorganic (Mineral) Acidosis: In acute metabolic acidosis caused by inorganic mineral acids (e.g., HCl, NH4Cl), excess extracellular H+ enters cells to be buffered by intracellular proteins (hemoglobin, histidyl residues) and inorganic phosphate. Because chloride cannot easily penetrate cellular membranes with H+, intracellular potassium shifts outward into the ECF to preserve electroneutrality. As a clinical rule of thumb, for every 0.10 unit drop in extracellular pH, serum potassium rises by approximately 0.4 to 0.6 mmol/L.
- Organic Acidosis Exception: In organic acidoses (lactic acidosis, diabetic ketoacidosis), the accompanying lipophilic organic anions (lactate, beta-hydroxybutyrate, acetoacetate) can permeate cell membranes alongside H+, or enter via monocarboxylate transporters. Consequently, intracellular H+ entry is electrically paired with organic anion entry, and transcellular K+ displacement is significantly attenuated. Hyperkalemia in DKA is driven primarily by insulin deficiency and hyperosmolality, not direct H+/K+ exchange.
Hypokalemia (<3.5 mmol/L)
Hypokalemia is defined as a serum potassium concentration < 3.5 mmol/L. Moderate hypokalemia (2.5-3.0 mmol/L) causes neuromuscular symptoms, while severe hypokalemia (< 2.5 mmol/L) precipitates rhabdomyolysis, ascending flaccid paralysis, and lethal cardiac arrhythmias.
Clinical & Electrocardiographic Manifestations
- Neuromuscular: Skeletal muscle weakness, painful cramps, hyporeflexia, ascending paralysis, paralytic ileus, and hypoventilation due to diaphragmatic weakness.
- Electrocardiogram (ECG) Changes:
- Progressive flattening and eventual inversion of T waves.
- Appearance of prominent U waves (a positive deflection following the T wave, representing delayed repolarization of Purkinje fibers).
- ST-segment depression.
- Apparent prolongation of the QT interval (more accurately the QU interval).
- Ventricular ectopy, torsades de pointes, and ventricular fibrillation.
+-----------------------------------------------------------------------------------------+
| Electrocardiographic Evolution in Hypokalemia |
+-----------------------------------------------------------------------------------------+
| R |
| / | |
| / | |
| / | T (Flattened) U (Prominent) |
| / | +---------------+ +---------------+ |
| / | | | | | |
| --P Q-------S-------+ +-----+ +-----------------------|
| ST Depression |
+-----------------------------------------------------------------------------------------+
Etiologies of Hypokalemia
- Decreased Dietary Intake: Starvation, anorexia nervosa, prolonged potassium-deficient parenteral nutrition.
- Transcellular Inward Shifts: Acute alkalosis, insulin administration (e.g., insulin drip during treatment of DKA), beta-2 adrenergic agonist administration (albuterol, terbutaline), refeeding syndrome (rapid carbohydrate refeeding stimulates insulin, driving potassium and phosphate into cells), and hypokalemic periodic paralysis.
- Renal Potassium Wasting:
- Diuretics: Loop diuretics (furosemide) and thiazides block upstream sodium reabsorption, increasing distal sodium delivery and flow rate to the CCD, which dramatically accelerates aldosterone-mediated potassium secretion.
- Mineralocorticoid Excess: Primary hyperaldosteronism (Conn syndrome), secondary hyperaldosteronism (renal artery stenosis, CHF), and Cushing syndrome (excess cortisol overwhelms renal 11beta-hydroxysteroid dehydrogenase type 2 [11beta-HSD2], stimulating mineralocorticoid receptors).
- Renal Tubular Acidosis (RTA): Both Type 1 (distal RTA, impaired H+ secretion) and Type 2 (proximal RTA, impaired HCO3- reabsorption) feature hypokalemia.
- Hypomagnesemia: Intracellular magnesium exerts an inhibitory brake on apical ROMK channels. Severe magnesium depletion removes this inhibitory brake, causing unrestricted renal potassium wasting that is completely refractory to potassium repletion until magnesium is corrected.
- Gastrointestinal Potassium Loss:
- Diarrhea, VIPoma, Villous Adenoma, Laxative Abuse: Stool fluid contains high potassium concentrations (~20-50 mmol/L).
- Vomiting and Nasogastric Suction: Although gastric juice contains only 5 to 10 mmol/L potassium, loss of gastric HCl causes metabolic alkalosis and volume contraction. The resulting hyperaldosteronism and secondary alkalemia drive profound renal potassium wasting, which accounts for > 90% of the potassium deficit in vomiting.
Hyperkalemia (>5.0 mmol/L)
Hyperkalemia is defined as a serum potassium concentration > 5.0 mmol/L. Severe hyperkalemia (> 6.5 mmol/L) is a medical emergency that can trigger sudden cardiac arrest without warning.
Electrocardiographic Sequence in Hyperkalemia
As extracellular potassium rises, cardiac conduction velocity slows progressively, generating a characteristic sequence of ECG changes:
- 5.5 to 6.5 mmol/L: Symmetrical, tall, narrow-based, peaked ("tented") T waves, best visualized in precordial leads V2 to V4.
- 6.5 to 7.5 mmol/L: Prolongation of the PR interval, flattening and eventual disappearance of P waves, and ST-segment depression.
- 7.5 to 8.5 mmol/L: Progressive widening of the QRS complex, merging with the T wave.
- > 8.5 mmol/L: The widened QRS merges completely with the T wave to form a smooth, biphasic sine wave pattern, followed immediately by ventricular fibrillation, asystole, or electromechanical dissociation.
+-----------------------------------------------------------------------------------------+
| Electrocardiographic Evolution in Hyperkalemia |
+-----------------------------------------------------------------------------------------+
| Tall, Peaked T Wave Wide QRS & Flat P Sine Wave Pattern|
| /| /| |
| / | / | /| |
| P / | +-----/ +-----+ / | |
| /| / | | | / | |
| -+ +---+ +------- --+ +-- -+ +---|
+-----------------------------------------------------------------------------------------+
Etiologies of True Hyperkalemia
- Impaired Renal Potassium Excretion:
- Renal Failure: Acute kidney injury (oliguric/anuric) or advanced chronic kidney disease (GFR < 15-20 mL/min). Damaged nephrons cannot excrete daily potassium loads.
- Mineralocorticoid Deficiency: Primary adrenal insufficiency (Addison disease; autoimmune or infectious destruction of adrenal cortex), congenital adrenal hyperplasia (21-hydroxylase deficiency), and hyporeninemic hypoaldosteronism (Type 4 RTA, common in diabetic nephropathy).
- Pharmacological Interference: Potassium-sparing diuretics (spironolactone, eplerenone, amiloride, triamterene), ACE inhibitors, Angiotensin Receptor Blockers (ARBs), direct renin inhibitors (aliskiren), NSAIDs (inhibit renal prostaglandin-mediated renin release), calcineurin inhibitors (cyclosporine, tacrolimus), and trimethoprim (structurally resembles amiloride and blocks ENaC).
- Transcellular Outward Shifts:
- Acute inorganic metabolic acidosis, severe insulinopenia and hyperosmolality in DKA, administration of succinylcholine (depolarizing neuromuscular blocker), and digitalis intoxication (inhibits Na+/K+-ATPase).
- Massive Tissue Breakdown & Cytolysis:
- Rhabdomyolysis (crush injuries, compartment syndrome, statin toxicity).
- Tumor Lysis Syndrome (TLS): Following chemotherapy for high-grade hematologic malignancies (Burkitt lymphoma, acute leukemia), rapid lysis of millions of malignant cells dumps vast quantities of potassium, phosphate, and uric acid into circulation, accompanied by severe secondary hypocalcemia.
- Massive intravascular hemolysis and extensive thermal burns.
Pseudohyperkalemia: Pre-Analytical Artifacts & Laboratory Recognition
Pseudohyperkalemia refers to an in vitro elevation in measured potassium concentration that occurs during or after specimen collection, while in vivo circulating plasma potassium is completely normal.
+-----------------------------------------------------------------------------------------+
| Summary of Pre-Analytical Causes of Pseudohyperkalemia |
+-----------------------------------------------------------------------------------------+
| Artifact Etiology Biochemical Mechanism Corrective Action |
+-----------------------------------------------------------------------------------------+
| In Vitro Hemolysis RBC intracellular K+ (105 mmol/L) is Redraw atraumatically; |
| 25-30x serum; cell lysis dumps K+. avoid fine-gauge needles. |
| |
| Prolonged Tourniquet & Local hypoxia/acidosis plus muscular Release tourniquet < 1 min|
| Fist Pumping contraction releases K+ from forearms. Avoid repetitive clenching|
| |
| Delayed Centrifugation Glycolytic depletion and refrigeration Separate serum from clot |
| / Room Temp Stasis inhibits Na+/K+-ATPase; K+ leaks out. within 1-2 hours. |
| |
| Severe Thrombocytosis Platelets degranulate during clotting; Collect in Lithium Heparin|
| (Plt > 500k - 1,000k) releases K+ into serum (absent plasma) plasma tube (Green Top). |
| |
| Severe Leukocytosis Fragile neoplastic leukocytes rupture Collect in Heparin; avoid |
| (WBC > 50,000/uL) during handling or pneumatic transit. pneumatic tube transport. |
| |
| EDTA Contamination K2EDTA contains potassium and avidly Strict order of draw; |
| (Order of Draw Error) chelates divalent cations (Ca2+, Mg2+).never pour lavender->green|
+-----------------------------------------------------------------------------------------+
Detailed Mechanisms of Pseudohyperkalemia
- In Vitro Hemolysis: Erythrocytes contain approximately 105 to 115 mmol/L of potassium. Lysis of as few as 0.5% of circulating RBCs releases sufficient intracellular potassium to elevate serum levels by 0.5 to 1.0 mmol/L. Hemolysis results from small-bore needles (25-gauge), excessive syringe aspiration pressure, vigorous tube shaking, or centrifuging incompletely clotted blood. Clinical analyzers calculate a spectrophotometric Hemolytic Index (H-index).
- Prolonged Tourniquet Application & Fist Pumping: Applying a tourniquet for > 1-2 minutes causes localized hemoconcentration and ischemic acidosis. Repetitive fist clenching or pumping causes exercising forearm skeletal muscles to release intracellular potassium into the antecubital venous circulation, falsely elevating local potassium by 1.0 to 2.0+ mmol/L.
- Delayed Separation & Temperature Artifacts: In unseparated blood standing at room temperature, erythrocytes consume glucose; when glucose is exhausted, ATP production ceases, disabling Na+/K+-ATPase. Potassium leaks down its concentration gradient into serum. If unseparated blood is refrigerated, Na+/K+-ATPase is immediately paralyzed while passive membrane leakage continues, causing massive in vitro potassium elevation.
- Severe Thrombocytosis (Platelet Count > 500,000 to 1,000,000/uL): During the coagulation process in a red-top or serum separator tube (SST), platelets aggregate and degranulate, releasing their intracellular potassium stores. Serum potassium rises by ~0.15 mmol/L for every 100,000/uL elevation in platelet count. In essential thrombocythemia, serum potassium may be reported as a panic value (> 6.5 mmol/L) while the patient is entirely asymptomatic and exhibits a normal ECG. Diagnostic Resolution: Simultaneously draw a lithium heparin plasma tube (green top). Because heparin prevents clotting and platelet degranulation, plasma potassium accurately reflects true in vivo concentration.
- Severe Leukocytosis (WBC > 50,000 to 100,000/uL): In chronic lymphocytic leukemia (CLL) or acute leukemias, fragile leukemic blasts rupture during centrifugation, mechanical handling, or transit through high-velocity pneumatic tube transport systems.
- EDTA Contamination (The Lavender-Top Tube Error):
- Dipotassium or tripotassium ethylenediaminetetraacetic acid (K2EDTA or K3EDTA) is the anticoagulant in hematology lavender-top tubes (~1.5-1.8 mg/mL blood).
- If a phlebotomist draws the lavender tube before the chemistry serum (red/gold) or heparin (green) tube, or if blood is poured from a lavender tube into a chemistry tube, the sample is contaminated with potassium and EDTA.
- The Classic Laboratory Diagnostic Pattern:
- Extreme Hyperkalemia: Potassium spikes dramatically (often > 8.0 to 20.0 mmol/L).
- Profound Hypocalcemia: EDTA avidly chelates divalent calcium, causing total calcium to drop to unphysiologically low levels (often < 2.0-4.0 mg/dL or below the analyzer detection limit).
- Undetectable Magnesium: Magnesium is similarly chelated (< 0.5 mg/dL).
- Inhibited Alkaline Phosphatase (ALP): ALP is a zinc- and magnesium-dependent metalloenzyme; chelation of its metallic cofactors eliminates catalytic activity, dropping measured ALP to near zero.
Chloride Homeostasis & Acid-Base Physiology
Chloride (Cl-) is the major extracellular anion, representing approximately 70% of the total anion content in extracellular fluid. The normal serum reference range is 98 to 107 mmol/L (or mEq/L).
Physiological Roles
- Maintains osmotic pressure and normal extracellular fluid volume alongside sodium.
- Preserves electrical neutrality across cellular membranes and across vascular compartments.
- Serves as the substrate for gastric hydrochloric acid (HCl) synthesis by gastric parietal cell H+/K+-ATPase pumps.
- Passively follows sodium reabsorption in the proximal tubule; actively reabsorbed in the thick ascending limb via NKCC2 and in the DCT via NCC.
Clinical Hypochloremia & Hyperchloremia
- Hypochloremia (< 98 mmol/L): Observed in loss of gastric secretions (persistent vomiting, nasogastric suction), loop and thiazide diuretic administration, chronic respiratory acidosis with renal compensation, and metabolic alkalosis. To preserve electroneutrality when chloride is lost, the kidneys must reabsorb bicarbonate, generating hypochloremic metabolic alkalosis.
- Hyperchloremia (> 107 mmol/L): Observed in dehydration, excessive infusion of 0.9% normal saline (154 mmol/L Na+ and 154 mmol/L Cl-), severe diarrhea (loss of HCO3--rich secretions), Renal Tubular Acidosis, and treatment with carbonic anhydrase inhibitors (acetazolamide). Accompanied by a reciprocal decline in plasma bicarbonate, producing Normal Anion Gap (Hyperchloremic) Metabolic Acidosis.
The Chloride Shift (Hamburger Phenomenon)
The Chloride Shift, historically designated the Hamburger phenomenon (described by Hartog Jakob Hamburger in 1892), is an electroneutral anion exchange process that operates across erythrocyte membranes to facilitate systemic CO2 transport from tissues to the lungs.
+-----------------------------------------------------------------------------------------+
| The Chloride Shift in Systemic Capillaries |
+-----------------------------------------------------------------------------------------+
| TISSUE CELL PLASMA ERYTHROCYTE (RBC) |
| |
| [ CO2 Produced ] ---> CO2 diffuses ---> CO2 + H2O |
| | (Carbonic Anhydrase) |
| v |
| H2CO3 |
| | |
| v |
| H+ + HCO3- |
| | | |
| Buffered by | |
| Deoxy-Hb v |
| [ Band 3 / AE1 ] ---> HCO3- to Plasma |
| [ Exchanger ] |
| Plasma Cl- ----------> [ ] ---> Cl- into RBC |
| |
| * Net Result: RBC takes up Cl- and water; RBC slightly swells; Venous Hct is ~1-2% ^ |
+-----------------------------------------------------------------------------------------+
Stepwise Molecular Mechanics
- Peripheral Tissue Capillaries (Forward Chloride Shift):
- Metabolically active parenchymal cells generate CO2, which diffuses into tissue capillaries and crosses the erythrocyte membrane.
- Within the erythrocyte, Carbonic Anhydrase (CA) rapidly hydrates CO2 to carbonic acid (H2CO3), which dissociates into H+ and bicarbonate (HCO3-):
CO2 + H2O <---> H2CO3 <---> H+ + HCO3- - Free H+ ions are immediately buffered by deoxygenated hemoglobin (which has released its oxygen due to tissue hypoxia and the Bohr effect). Deoxyhemoglobin is a weaker acid and more effective buffer than oxyhemoglobin.
- As intracellular [HCO3-] rises, it is transported out of the erythrocyte into plasma down its concentration gradient via the Band 3 anion exchanger (Anion Exchanger 1 / AE1 / SLC4A1).
- To maintain electrical neutrality, an equivalent quantity of chloride (Cl-) moves from plasma into the erythrocyte in a strict 1:1 electroneutral exchange.
- Because intracellular solute concentration increases (Cl- enters and is osmotically active, while H+ is buffered), water follows osmotically, causing the erythrocyte to swell slightly. Consequently, the hematocrit of venous blood is approximately 1% to 2% higher than that of arterial blood.
- Pulmonary Capillaries (Reverse Chloride Shift):
- In alveolar capillaries, the high partial pressure of oxygen drives oxygen binding to deoxyhemoglobin, forming oxyhemoglobin.
- Oxyhemoglobin releases its buffered H+ ions (the Haldane effect).
- Extracellular plasma HCO3- is transported into the erythrocyte via Band 3, while intracellular Cl- exits back into the plasma.
- Carbonic anhydrase converts H+ + HCO3- back into H2O and CO2. The dissolved CO2 diffuses across the alveolar-capillary membrane and is exhaled during ventilation.
Sweat Chloride Testing for Cystic Fibrosis
Quantitative sweat chloride analysis is the established gold standard laboratory diagnostic test for Cystic Fibrosis (CF).
+-----------------------------------------------------------------------------------------+
| Pathophysiology of CFTR in the Sweat Duct |
+-----------------------------------------------------------------------------------------+
| Normal Sweat Duct: |
| Primary sweat (isotonic) --> CFTR reabsorbs Cl- --> ENaC reabsorbs Na+ --> Dilute Sweat|
| ([Cl-] < 30) |
| |
| Cystic Fibrosis Sweat Duct (CFTR Mutation / ΔF508): |
| Primary sweat (isotonic) --> Defective CFTR (NO Cl- reabsorption) --> ENaC blocked |
| --> Hypertonic Sweat ([Cl-] >= 60 mmol/L) |
+-----------------------------------------------------------------------------------------+
Molecular Pathophysiology
Cystic Fibrosis is an autosomal recessive disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene on chromosome 7q31.2 (the most common mutation is the deletion of phenylalanine at position 508, ΔF508 or p.Phe508del). CFTR functions as a cAMP-regulated ATP-gated apical chloride channel. In the reabsorptive coiled duct of normal sweat glands, CFTR actively reabsorbs chloride from primary isotonic sweat, with sodium following passively via ENaC to maintain electroneutrality, producing hypotonic final sweat ([Cl-] < 30 mmol/L). In CF, mutated CFTR channels fail to reabsorb chloride; sodium reabsorption is simultaneously impeded, producing sweat with pathognomonically elevated concentrations of sodium and chloride.
Standardized Diagnostic Testing Protocol
- Sweat Stimulation via Pilocarpine Iontophoresis:
- Pilocarpine (a cholinergic muscarinic agonist) is applied to the flexor surface of the forearm or thigh.
- A battery-powered electrical iontophoresis instrument delivers a mild controlled direct current (~1.5 to 4.0 mA) for 5 minutes, driving positively charged pilocarpine into subcutaneous tissue to stimulate local eccrine sweat glands.
- Sweat Collection:
- Sweat is collected for strictly 30 minutes using either the Macroduct coiled microbore tubing system or the classic Gibson-Cooke gauze/filter paper technique.
- Minimum Specimen Quantity Requirements: To prevent evaporative artifact, a minimum of 15 μL of sweat (Macroduct) or 75 mg of sweat (Gibson-Cooke) must be collected, corresponding to a minimum sweat secretion rate of >= 1 g/m2/min. Insufficient collection (QNS) invalidates testing.
- Quantitative Analytical Methodology:
- Coulometric Titration (Chloridometry): The reference analytical method. Silver ions (Ag+) are electrochemically generated at a constant rate from a silver anode. Silver ions precipitate chloride as insoluble silver chloride (Ag+ + Cl- -> AgCl precipitate). When all chloride is consumed, appearance of free Ag+ triggers an amperometric detector circuit; titration time is directly proportional to sweat chloride concentration.
- Ion-Selective Electrode (ISE): Direct potentiometric evaluation using a chloride-selective membrane.
+-----------------------------------------------------------------------------------------+
| Cystic Fibrosis Foundation Sweat Chloride Diagnostic Cutoffs |
+-----------------------------------------------------------------------------------------+
| Sweat Chloride Concentration Clinical Interpretation Subsequent Action |
+-----------------------------------------------------------------------------------------+
| <= 29 mmol/L Normal / CF Unlikely No further testing unless |
| clinical symptoms persist |
| |
| 30 to 59 mmol/L Intermediate / Equivocal Repeat sweat test; perform |
| expanded CFTR gene sequencing|
| |
| >= 60 mmol/L Positive / Diagnostic of Confirms diagnosis of CF |
| Cystic Fibrosis (repeat once to confirm) |
+-----------------------------------------------------------------------------------------+
According to Cystic Fibrosis Foundation consensus guidelines, a sweat chloride >= 60 mmol/L on two separate occasions, in the presence of characteristic clinical symptoms (recurrent bronchopulmonary infections, pancreatic exocrine insufficiency, meconium ileus) or a positive newborn screening immunoreactive trypsinogen (IRT) assay, definitively establishes the diagnosis of Cystic Fibrosis.
Test Your Knowledge
A routine outpatient chemistry panel on a 54-year-old female yields the following startling results: Sodium = 139 mmol/L; Potassium = 14.8 mmol/L; Total Calcium = 1.8 mg/dL; Magnesium = 0.2 mg/dL; Alkaline Phosphatase = 2 U/L. The patient feels completely well and an immediate rhythm strip shows normal sinus rhythm without peaked T waves or QRS widening. What pre-analytical collection error accounts for these results?
A
B
C
D
Test Your Knowledge
During systemic capillary respiration, carbon dioxide produced by peripheral tissues diffuses into erythrocytes and is converted to bicarbonate by carbonic anhydrase. Which statement precisely describes the subsequent Hamburger phenomenon (chloride shift)?
A
B
C
D
Test Your Knowledge
A 67-year-old male with essential thrombocythemia undergoes routine monitoring. His CBC reveals: Platelets = 1,450,000/uL; WBC = 8.2 x 10^3/uL; Hemoglobin = 14.5 g/dL. A serum chemistry panel reveals a potassium of 6.8 mmol/L (panic value). The technologist inspects the serum and notes zero visible hemolysis (H-index is negative). The patient's ECG is completely normal. What laboratory action must be taken to obtain an accurate potassium measurement?
A
B
C
D